Mona Health
Detect and to prevent diseases by providing Artificial Intelligence based screening solutions with an eye scan, at the doorstep of the patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $1.8m | Seed | |
| Total Funding | 000k | ||
| EUR | 2022 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Mona Health is an innovative startup specializing in the development of software applications for retinal image analysis and disease screening. The company leverages advanced artificial intelligence (AI) and machine learning techniques to identify and manage major retinal diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration at early stages. By integrating retinal scans with personal health data, Mona Health's technology can also assess the impact of various risk factors like diabetes, smoking, obesity, high cholesterol, hypertension, and inactivity.
The primary clients of Mona Health are healthcare providers, including primary care physicians and eye specialists, who incorporate retinal screening into regular health checkups. This service is particularly beneficial for patients with chronic conditions such as diabetes, where annual eye assessments are recommended to prevent vision loss. The company operates in the health technology market, focusing on AI-driven diagnostic tools that enhance early disease detection and improve patient outcomes.
Mona Health's business model revolves around selling its AI-powered software solutions to healthcare providers and institutions. These solutions, such as MONA DR for diabetic retinopathy and MONA GLC for glaucoma, offer fast and accurate predictions, thereby improving the quality of life for patients and reducing the overall burden on healthcare systems. The company generates revenue through software licensing, subscription fees, and potentially through partnerships with healthcare organizations and research institutions.
In summary, Mona Health is at the forefront of using AI to revolutionize retinal disease screening and management, providing valuable tools for early detection and intervention.
Keywords: AI, retinal screening, diabetic retinopathy, glaucoma, early detection, healthcare providers, machine learning, disease management, health technology, software solutions.